Dr. Landreneau is a mesothelioma surgeon with nearly 30 years of experience. In 2015, he opened his own practice, Landreneau Thoracic Surgical Associates.
Dr. Landreneau is a thoracic surgeon who has amassed nearly three decades of surgical experience. He is now director of the Esophageal and Lung Institute at Allegheny General Hospital in Pittsburgh, Pennsylvania.
He recently left the Ochsner Cancer Institute in New Orleans. Landreneau held several titles at Ochsner, including vice chairman of the department of surgery’s clinical program development, chief of general thoracic surgery and medical director. In 2013, he performed Louisiana’s first surgical debulking procedure with hyperthermic chemotherapy for mesothelioma, a technique he perfected at UPMC.
Previously, Landreneau spent 25 years treating mesothelioma patients at the University of Pittsburgh Medical Center (UPMC).
He specializes in minimally invasive surgery and video-assisted thoracic surgery (VATS). In addition to mesothelioma, Dr. Landreneau offers surgical options for patients with lung cancer, esophageal cancer and several other cancerous and benign conditions of the chest.
After graduating from Louisiana State University in Baton Rouge, Landreneau studied medicine at Louisiana State University Medical School. He completed his medical training with honors, and was elected to the Alpha Omega Alpha medical honor society. Dr. Landreneau went on to complete a residency in general surgery at the University of Texas-Southwestern Medical Center in Dallas, and a residency in thoracic surgery at the University of Michigan, Ann Arbor. He is board certified in general and thoracic surgery.
Landreneau is a member of several professional medical organizations, including the American Association for Thoracic Surgery, the American College of Chest Physicians, the American Surgical Association, the American Society of Clinical Oncology and the Society of Surgical Oncology.
He has written more than 350 peer-reviewed journal articles on his specialties, and is a leading thoracic oncologic clinical investigator with the American College of Surgeons Oncology Group (ACOSOG). Landreneau is also a leading member of the Alliance Cancer Cooperative Group, which is comprised of several national cancer groups.
View our resources for patients and familiesGet Help Today